Increased plasma levels of adrenomedullin in patients with pulmonary hypertension
Mikio Kakishita(National Cerebral and Cardiovascular Center), Takeyoshi Kunieda(National Cerebral and Cardiovascular Center), Toshio Nishikimi(Kyoto University), Norifumi Nakanishi(National Cerebral and Cardiovascular Center), Kengo FUKUSHIMA, Shuichi TAKISHITA, Yoshiaki Okano(National Cerebral and Cardiovascular Center), Toru SATOH, Hisayuki Matsuo(National Cerebral and Cardiovascular Center), Shingo Kyotani(National Cerebral and Cardiovascular Center), Atsuro Miyata(Kagoshima University), Noritoshi Nagaya(National Cerebral and Cardiovascular Center), Kenji KANGAWA
Cited by 49
Related Papers
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
The role of natriuretic peptides in cardioprotection
|Cardiovascular Research|2005|483
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
|Journal of Clinical Investigation|1994|478
Mutations of the TGF-β type II receptorBMPR2 in pulmonary arterial hypertension
|Human Mutation|2006|404